Recent advances in the molecular genetics of hypertrophic cardiomyopathy.
about
The locus of a novel gene responsible for arrhythmogenic right-ventricular dysplasia characterized by early onset and high penetrance maps to chromosome 10p12-p14.Use of intravenous antiarrhythmics to identify concealed Brugada syndromeThe influence of Angiotensin converting enzyme and angiotensinogen gene polymorphisms on hypertrophic cardiomyopathyAltered cardiac excitation-contraction coupling in mutant mice with familial hypertrophic cardiomyopathyHeat shock protein 90 regulates IκB kinase complex and NF-κB activation in angiotensin II-induced cardiac cell hypertrophy.Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice.Hypertrophic cardiomyopathy complicated by severe bradycardias: a pedigree report.Cardiac hypertrophy: signal transduction, transcriptional adaptation, and altered growth control.Mitochondrial fission is required for cardiomyocyte hypertrophy mediated by a Ca2+-calcineurin signaling pathway.A transgenic rabbit model for human hypertrophic cardiomyopathy.Athlete"s heart and hypertrophic cardiomyopathy.Genetic aspects of arrhythmias.Benazepril and subclinical feline hypertrophic cardiomyopathy: a prospective, blinded, controlled study.Genomics of heart failure.Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutationHypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.Malalignment of the sarcomeric filaments in hypertrophic cardiomyopathy with cardiac myosin heavy chain gene mutationThe rare association of tetralogy of Fallot with hypertrophic cardiomyopathy. Report of 2 neonatal patients.Transgenic rabbit models for studying human cardiovascular diseases.The association between brain natriuretic peptide and tissue Doppler parameters in children with hypertrophic cardiomyopathy.Use of cardiovascular magnetic resonance for diagnosis and management in hypertrophic cardiomyopathy.Functional analysis of the mutations in the human cardiac beta-myosin that are responsible for familial hypertrophic cardiomyopathy. Implication for the clinical outcomeImaging techniques in the evaluation and management of hypertrophic cardiomyopathy.Direct measurement of salt-bridge solvation energies using a peptide model system: implications for protein stability.Mandatory ECG screening of athletes: is this question now resolved?ZAK induces cardiomyocyte hypertrophy and brain natriuretic peptide expression via p38/JNK signaling and GATA4/c-Jun transcriptional factor activation.The molecular genetics of arrhythmias and sudden death.Enhanced Expression of FRA16B using AT-Rich DNA Binding Chemicals in a Woman with Secondary Amenorrhoea.Molecular genetic basis of hypertrophic cardiomyopathy: genetic markers for sudden cardiac death.Hypertrophic cardiomyopathy in daily practice: an introduction on diagnosis, prognosis and treatment.Genetic polymorphism of angiotensin-converting enzyme and hypertrophic cardiomyopathy risk: A systematic review and meta-analysis.Augmented exercise plasma noradrenaline with impaired chronotropic responsiveness in patients with hypertrophic cardiomyopathy.Comparative transcriptomics implicates mechanisms of evolved pollution tolerance in a killifish population.Association of angiotensin-converting enzyme activity and polymorphism with echocardiographic measures in familial and nonfamilial hypertrophic cardiomyopathy.
P2860
Q24534286-56E646A8-C837-4F4F-8194-802DB1BD1E31Q24792476-32828269-9431-4238-940C-FFCE12452317Q27002339-0B9DE83C-6512-429B-8DA5-B3DAF6D7332BQ28505267-34BAF3C7-991A-4C51-906F-8E0BE9BDE5ACQ29346968-E3DBDBC9-390D-4B3A-9342-6786F13721BDQ30500669-683AB579-D252-4641-9612-498757B09929Q33147359-4E3E6576-CD0E-479D-8B17-54BBAF1F7AEFQ33692375-70A61362-39D6-4856-AFEA-44B08730A7D8Q33757346-840914CE-11F9-4365-9C50-02B7752C28E0Q33903354-23DE9633-052A-41CA-AA16-DD9895DC2C02Q34027472-1977F87E-ED2C-4EFA-8B6D-88DCE8FD636CQ34263609-856995F6-EA00-48DF-9947-10B54106C6BCQ34557206-56EE6EB7-DDCE-4446-9C5B-0CCD64694609Q34588881-BA691BE5-EBBD-43E7-9CEB-7973D9A11239Q34627120-3B16AAF1-A644-4928-8729-D7E162506514Q34627221-798E6ECF-F9A4-4A7D-83F5-BB8141EE5196Q35376769-E1F5BF5F-1D94-49FA-A40C-B4B7AA0BFC97Q35566680-D6F12D70-D7DE-4C96-AFBF-E78021AA8F6CQ35662665-F44BB1E0-9D7D-4F7F-81F4-1BDC91FD9CEFQ36481289-31D2A578-3FCE-4A11-A2BB-A41E16FA6EABQ36614242-98BAB308-1B4C-42DE-8BBE-31B4CECFED21Q36760559-093088A4-ECC7-43B2-A67F-5ED388D40B50Q37362212-5ED0E47C-31F9-4177-BCFC-A4F4A0A9A897Q37590458-38C16505-A25D-4246-8266-C7610CC27267Q37682818-70FD1190-F174-43E3-9D7F-80759CEAE7D1Q37953505-B55767B0-58BB-4909-B1F2-642FAA99B713Q38887747-AB4BD846-3B87-47B5-85A6-6A1EAEAB2158Q40846746-AD9F1ACA-A409-48EA-B542-7C049B9ACBE8Q41161142-35FD9E9A-E6CE-4065-B5DB-BEC101AB0334Q41706960-FD5EA4F9-9376-42D8-877A-BE2093E50D76Q42339402-E02500A1-36EE-44CB-A393-0F93A165D82AQ47196704-3256C020-6B2E-4118-8795-98FA392EA3BBQ50847997-845D2DE5-AD79-4E75-A29A-DB49E1364A8BQ51899104-FCDBA2D7-9195-4A50-8131-D29DEB070D66Q54485567-7A6AE7F6-9297-4F56-80BE-AC41132A2F2E
P2860
Recent advances in the molecular genetics of hypertrophic cardiomyopathy.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Recent advances in the molecular genetics of hypertrophic cardiomyopathy.
@en
type
label
Recent advances in the molecular genetics of hypertrophic cardiomyopathy.
@en
prefLabel
Recent advances in the molecular genetics of hypertrophic cardiomyopathy.
@en
P356
P1433
P1476
Recent advances in the molecular genetics of hypertrophic cardiomyopathy.
@en
P2093
P304
P356
10.1161/01.CIR.92.5.1336
P407
P577
1995-09-01T00:00:00Z